| (Values in U.S. Thousands) | Mar, 2026 | Dec, 2025 | Sep, 2025 | Mar, 2025 | Sep, 2024 |
| Sales | 108,390 | 96,050 | 83,520 | 58,960 | 38,420 |
| Sales Growth | +12.85% | +15.00% | +41.66% | +53.46% | unch |
| Net Income | 17,970 | 4,420 | 5,710 | -3,990 | -14,900 |
| Net Income Growth | +306.56% | -22.59% | +243.11% | +73.22% | unch |
Billiontoone Inc Cl A (BLLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
BillionToOne Inc. is a molecular diagnostics company. BillionToOne Inc. is based in headquartered in Menlo Park, California.
Fiscal Year End Date: 12/31